Optimizing the Design of Dementia with Lewy Bodies Trials

Ensuring enrollment and end point selection in dementia Lewy body clinical research

Read more

Although well described for several decades, DLB remains a diagnostic challenge due to the clinicopathological overlap with other neurodegenerative diseases such as AD, PDD, and FTD.


Chief Development Officer
Vice President, Scientific Solutions, Neuroscience

Want to learn more about Worldwide Clinical Trials?